The estimated Net Worth of William Walter Goodmen is at least $969 Thousand dollars as of 20 August 2012. Mr Goodmen owns over 16,667 units of Staar Surgical Co stock worth over $959,827 and over the last 14 years he sold STAA stock worth over $9,573.
Mr has made over 5 trades of the Staar Surgical Co stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 16,667 units of STAA stock worth $78,168 on 20 August 2012.
The largest trade he's ever made was exercising 16,667 units of Staar Surgical Co stock on 20 August 2012 worth over $78,168. On average, Mr trades about 4,544 units every 41 days since 2010. As of 20 August 2012 he still owns at least 31,667 units of Staar Surgical Co stock.
You can see the complete history of Mr Goodmen stock trades at the bottom of the page.
William Goodmen is the VP of Global HR at Staar Surgical Co.
Mr Goodmen is 66, he's been the VP of Global HR of Staar Surgical Co since . There are 2 older and 19 younger executives at Staar Surgical Co. The oldest executive at Staar Surgical Co. is John Moore, 76, who is the Independent Director.
William's mailing address filed with the SEC is 1911 WALKER AVE, , MONROVIA, CA, 91016.
Over the last 21 years, insiders at Staar Surgical Co have traded over $305,974,767 worth of Staar Surgical Co stock and bought 10,576,326 units worth $122,359,752 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Partners, L.P.Bradsher Neal..., and Gilbert H Kliman. On average, Staar Surgical Co executives and independent directors trade stock every 26 days with the average trade being worth of $1,643,742. The most recent stock trade was executed by Arthur C Butcher on 12 August 2024, trading 1,315 units of STAA stock currently worth $49,957.
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
Staar Surgical Co executives and other stock owners filed with the SEC include: